Riddhi Mavani: After Years of Learning, Experimentation, and Perseverance, I’m Delighted to Share That I Have Successfully Completed My Ph.D
Riddhi Mavani, PhD in Biotechnology, shared a post on LinkedIn:
“Proud to share a major milestone in my academic journey!
After years of learning, experimentation, and perseverance, I’m delighted to share that I have successfully completed my Ph.D. in Biotechnology from Navrachana University, Vadodara.
My research, titled “Studies on elicitation and biotransformation driven modulation of secondary metabolites in Mesosphaerum suaveolens (L.) Kuntze and Ocimum basilicum L. : an in vitro approach,” focused on developing biotechnological strategies to enhance secondary metabolites from medicinal and aromatic plants.
Guided by Dr. Monisha Kottayi (Guide) and Parth Pandya (Co-guide), my work also explored the efficacy of Arbutin against breast and ovarian cancer cell lines, bridging plant biotechnology and cancer research.
I’m deeply grateful to my mentors for their constant support, to Dr Chirag Ghevariya and Dr Kruti Pandya for their valuable inputs, and my colleagues Harsh Shah, PhD Hetvi Shah and Mr. Deepak Arya for their assistance in the overall research journey.
This Ph.D. is not just an end, it’s the beginning of new explorations in science, discovery, and innovation. ”

Stay informed with Hemostasis Today.
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial